New cholesterol lowering agent after myocardial infarction?

被引：0
|
作者：
Rostadmo, Martine
机构：
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2015年 / 135卷 / 17期
关键词：
D O I：
10.4045/tidsskr.15.0759
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1548 / 1548
页数：1
相关论文
共 50 条
  • [41] SAFETY AND EFFECTIVENESS OF PROBUCOL AS A CHOLESTEROL LOWERING AGENT
    TEDESCHI, RE
    MARTZ, BL
    TAYLOR, HA
    CERIMELE, BJ
    ARTERY, 1982, 10 (01) : 22 - 34
  • [42] Gugulipid: A natural cholesterol-lowering agent
    Urizar, NL
    Moore, DD
    ANNUAL REVIEW OF NUTRITION, 2003, 23 : 303 - 313
  • [43] CHOLESTEROL-LOWERING AGENT MYOPATHY (CLAM)
    LONDON, SF
    GROSS, KF
    RINGEL, SP
    NEUROLOGY, 1991, 41 (07) : 1159 - 1160
  • [44] Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case report
    Sjuls, Simon
    Jensen, Ulf
    Littmann, Karin
    Bruchfeld, Annette
    Brinck, Jonas
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2021, 5 (05) : 1 - 6
  • [45] Low-density lipoprotein cholesterol lowering therapy and target level attainment after a recent myocardial infarction - nationwide cohort study
    Allahyari, A.
    Jernberg, T.
    Lautsch, D.
    Lundman, P.
    Hagstrom, E.
    Schubert, J.
    Boggs, R.
    Salomonsson, S.
    Ueda, P.
    EUROPEAN HEART JOURNAL, 2019, 40 : 429 - 429
  • [46] LIPID LOWERING THERAPIES AND CHOLESTEROL LEVELS AFTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: SINGLE CENTER EXPERIENCE OF SECONDARY PREVENTION
    Simsek, B.
    Avci, I. I.
    Zeren, G.
    Tanik, O.
    Gungor, B.
    ATHEROSCLEROSIS, 2019, 287 : E206 - E206
  • [47] Is Insulin the Preferred Compound in Lowering Glucose Levels in Patients After a Myocardial Infarction?
    Rensing, Katrijn L.
    Kastelein, John J. P.
    Twickler, Marcel
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (17) : 1636 - 1637
  • [48] Plane lowering of the heart rate dramatically improves the prognosis after myocardial infarction
    不详
    HERZ, 2007, 32 (08) : A13 - A13
  • [49] Lipid-lowering drug use and cardiovascular events after myocardial infarction
    Klungel, OH
    Heckbert, SR
    de Boer, A
    Leufkens, HGM
    Sullivan, SD
    Fishman, PA
    Veenstra, DL
    Psaty, BM
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (05) : 751 - 757
  • [50] TIME FOR REESTABLISHMENT OF SERUM-LIPID LOWERING AFTER MYOCARDIAL-INFARCTION
    DEFAIRE, U
    ACTA MEDICA SCANDINAVICA, 1988, 223 (05): : 385 - 387
12345